G6 Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066

E. L. Kwak, D. Ross Camidge, JeVrey W. Clark, Geoffrey I. Shapiro, Robert G. Maki, Mark J. Ratain, Benjamin Solomon, Yu Jeong Bang, S. Ou, Ravi Salgia

European Journal of Cancer Supplements · 2009 · 22 citations · 0 references

Concepts